Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Genomics of Limited-Stage Diffuse Large B-Cell Lymphoma Developing Late Relapse: Analysis of Gene Alterations in Paired Primary and Late Relapsed Tumors By Target Sequencing

Tomotaka Suzuki, MD, Suguru Fukuhara, MD, Junko Nomoto, PhD, Satoshi Yamashita, PhD, Akiko Miyagi Maeshima, MD PhD, Yuta Ito, MD, Shunsuke Hatta, MD PhD, Sayako Yuda, MD PhD, Shinichi Makita, MD, PhD, Wataru Munakata, MD PhD, Tatsuya Suzuki, MD, PhD, Dai Maruyama, MD PhD, Hirokazu Taniguchi, MD, PhD, Toshikazu Ushijima, MD PhD, Koji Izutsu, MDPhD, Kensei Tobinai, MD PhD, Yukio Kobayashi, MDDSc

Blood (2018) 132 (Supplement 1): 1571.

https://doi.org/10.1182/blood-2018-99-111262

Published: 2018

Journal Articles

Impact of the Double Expression of MYC and BCL2 on Outcomes of Primary Refractory Diffuse Large B-Cell Lymphoma Following R-CHOP Chemoimmunotherapy

Tomotaka Suzuki, MD, Dai Maruyama, MD PhD, Akiko Miyagi Maeshima, MD PhD, Kinuko Tajima, Yuta Ito, MD, Shunsuke Hatta, MD PhD, Sayako Yuda, MD, PhD, Shinichi Makita, MD, PhD, Suguru Fukuhara, MD, Wataru Munakata, MD PhD, Tatsuya Suzuki, MD, PhD, Hirokazu Taniguchi, MD, Yukio Kobayashi, MD PhD, Koji Izutsu, MD, PhD, Kensei Tobinai, MD PhD

Blood (2017) 130 (Supplement 1): 2846.

https://doi.org/10.1182/blood.V130.Suppl_1.2846.2846

Published: 2017

Journal Articles

Prolonged Lymphocytepenia after Bendamustine with or without Rituximab Treatment in Patients with Relapsed or Refractory Indolent B-Cell and Mantle Cell Lymphoma

Hideaki Saito, MD, Dai Maruyama, MD PhD, Akiko Miyagi Maeshima, MD PhD, Shin-ichi Makita, MD, Hideaki Kitahara, MD, Ken-ichi Miyamoto, MD, Suguru Fukuhara, MD, Wataru Munakata, MD, Tatsuya Suzuki, MD PhD, Yukio Kobayashi, Hirokazu Taniguchi, MD PhD, Kensei Tobinai

Blood (2014) 124 (21): 3066.

https://doi.org/10.1182/blood.V124.21.3066.3066

Published: 2014

Journal Articles

Influence of the Watch and Wait Strategy on the Clinical Outcome in Patients with Follicular Lymphoma in the Rituximab Era

Sayako Yuda, MD, Dai Maruyama, MD PhD, Akiko Miyagi Maeshima, MD PhD, Shin-ichi Makita, MD, Hideaki Kitahara, MD, Miyamoto Ken-ichi, MD, Suguru Fukuhara, MD, Wataru Munakata, MD, Tatsuya Suzuki, MD PhD, Yukio Kobayashi, MD PhD, Kinuko Tajima, Hirokazu Taniguchi, MD PhD, Kensei Tobinai

Blood (2014) 124 (21): 4475.

https://doi.org/10.1182/blood.V124.21.4475.4475

Published: 2014

Journal Articles

The Impact of Concurrent Expression of MYC and BCL2 on Outcomes of Localized Primary Gastric Diffuse Large B-Cell Lymphoma Undergoing Rituximab-Containing Chemotherapy with or without Radiotherapy

Akihisa Kawajiri, MD, Dai Maruyama, MD PhD, Akiko Miyagi Maeshima, MD PhD, Shin-ichi Makita, MD, Hideaki Kitahara, MD, Ken-ichi Miyamoto, MD, Suguru Fukuhara, MD, Tatsuya Suzuki, MD PhD, Wataru Munakata, MD, Yukio Kobayashi, Kinuko Tajima, Jun Itami, MD PhD, Hirokazu Taniguchi, MD PhD, Kensei Tobinai

Blood (2014) 124 (21): 1761.

https://doi.org/10.1182/blood.V124.21.1761.1761

Published: 2014

Journal Articles

Phase I Study of Clofarabine (JC0707) in Adult Japanese Patients with Acute Myeloid Leukemia (AML)

Takahiro Yamauchi, MD, PhD, Tatsuya Suzuki, MD, PhD, Kiyoshi Ando, MD, PhD, Tadashi Nagai, MD, PhD, Kazuhiko Kakihana, MD, PhD, Yasuhiko Miyata, MD, PhD, Reginald Ewesuedo, MD, Yasuhiro Tabata, MD, PhD, Michinori Ogura

Blood (2011) 118 (21): 4295.

https://doi.org/10.1182/blood.V118.21.4295.4295

Published: 2011

Journal Articles

Phase I Study of a New Humanized Anti-CD20 Monoclonal Antibody (LY2469298) in Japanese Patients (pts) with Relapsed or Refractory Follicular Lymphoma (FL) Pretreated with Rituximab-Containing Regimen

Michinori Ogura, MD, PhD, Kensei Tobinai, MD, PhD, Toshiki Uchida, MD, PhD, Yukio Kobayashi, MD, PhD, Takashi Oyama, MD, Takashi Watanabe, MD, PhD, Tatsuya Suzuki, MD, PhD, Dai Maruyama, MD, PhD, Masanobu Kasai, MD, Masakazu Mori, MD, Tomomi Matsue, Damien Cronier, PhD, James E Wooldridge, MD, Minori Koshiji, MD, PhD

Blood (2010) 116 (21): 3942.

https://doi.org/10.1182/blood.V116.21.3942.3942

Published: 2010

Journal Articles

Phase I Study of Forodesine (BCX1777), An Oral PNP Inhibitor In Patients with Relapsed or Refractory T/NK Malignancies.

Kunihiro Tsukasaki, MD, PhD, Michinori Ogura, MD, PhD, Hirokazu Nagai, MD, PhD, Jun Taguchi, MD, PhD, Tatsuya Suzuki, MD, PhD, Dai Maruyama, MD, PhD, Uchida Toshiki, MD, PhD, Takashi Oyama, MD, PhD, Tomomitsu Hotta, MD, PhD, Kensei Tobinai, MD, PhD

Blood (2010) 116 (21): 1796.

https://doi.org/10.1182/blood.V116.21.1796.1796

Published: 2010

NARROW

Genomics of Limited-Stage Diffuse Large B-Cell Lymphoma Developing Late Relapse: Analysis of Gene Alterations in Paired Primary and Late Relapsed Tumors By Target Sequencing

Impact of the Double Expression of MYC and BCL2 on Outcomes of Primary Refractory Diffuse Large B-Cell Lymphoma Following R-CHOP Chemoimmunotherapy

Prolonged Lymphocytepenia after Bendamustine with or without Rituximab Treatment in Patients with Relapsed or Refractory Indolent B-Cell and Mantle Cell Lymphoma

Influence of the Watch and Wait Strategy on the Clinical Outcome in Patients with Follicular Lymphoma in the Rituximab Era

The Impact of Concurrent Expression of MYC and BCL2 on Outcomes of Localized Primary Gastric Diffuse Large B-Cell Lymphoma Undergoing Rituximab-Containing Chemotherapy with or without Radiotherapy

Phase I Study of Clofarabine (JC0707) in Adult Japanese Patients with Acute Myeloid Leukemia (AML)

Phase I Study of a New Humanized Anti-CD20 Monoclonal Antibody (LY2469298) in Japanese Patients (pts) with Relapsed or Refractory Follicular Lymphoma (FL) Pretreated with Rituximab-Containing Regimen

Phase I Study of Forodesine (BCX1777), An Oral PNP Inhibitor In Patients with Relapsed or Refractory T/NK Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only